INT10187
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
While IL2 receptor (IL2R) was expressed on 20-50% of tumor cells prior to therapy, recurrent tumor was IL2R negative in three of the patients. | |||||||||||||||
| |||||||||||||||
|
While IL2 receptor (IL2R) was expressed on 20-50% of tumor cells prior to therapy, recurrent tumor was IL2R negative in three of the patients. | |||||||||||||||
| |||||||||||||||
|
While IL2 receptor (IL2R) was expressed on 20-50% of tumor cells prior to therapy, recurrent tumor was IL2R negative in three of the patients. | |||||||||||||||
| |||||||||||||||
|
Transfer activity was lost when cells were depleted of CD4(+) or CD25(+) subpopulations. | |||||||||||||||
| |||||||||||||||
|
This result suggests that a penetrating ocular injury at an early stage after an AC injection of OVA does not alter the expression of CD4+CD25+Foxp3+T cells and thereby does not result in the induction of ACAID. | |||||||||||||||
| |||||||||||||||
|
Mucosal mast cells were quantitated, and the presence or absence of CD25 expression on mast cells was determined. | |||||||||||||||
| |||||||||||||||
|
Recently, expression of CD25 by mast cells in bone marrow has been shown to be specific for SM. | |||||||||||||||
| |||||||||||||||
|
(CD25) and/or production of certain immunoregulatory cytokines [33, 34]. | |||||||||||||||
| |||||||||||||||
|
CD25, i.e. the IL2R, is more easily detected in vitro), and to its kinetics, peaking relatively late (whereas e.g. | |||||||||||||||
| |||||||||||||||
|
Unfortunately, the cell surface proteins on Tregs (for example; CD25, CTLA4) are also expressed on other immune cells such as activated T lymphocytes [46]. | |||||||||||||||
| |||||||||||||||
|
Lastly, we observed an expansion of CD4+CD25+FoxP3+ Treg during the induction of ACAID. | |||||||||||||||
| |||||||||||||||
|
In addition, mast cells in all SM cases were positive for CD25, whereas GI mucosal mast cells in UP and all other control cases were negative. | |||||||||||||||
| |||||||||||||||
|
Strikingly, M2-transduced cells expressed higher levels of CD25 as compared to cells transduced with the control retrovirus, although the MFI of CD25 was similar between the two populations (Figure 3A). | |||||||||||||||
| |||||||||||||||
|
profile after gating on the CD4+CD25+ and CD4+CD25? | |||||||||||||||
| |||||||||||||||
|
profile after gating on the CD4+CD25+ and CD4+CD25? | |||||||||||||||
| |||||||||||||||
|
The frequency of Tregs determined as CD4+CD25+CD127lowFOXP3+ was followed in blood, spleen and PDLN of mice immunised at 9 weeks of age. | |||||||||||||||
| |||||||||||||||
|
Interestingly, as shown in Fig. 6a, upon in vitro re-stimulation with plate-bound anti-CD3 and soluble anti-CD28, CD4+CD25+ and CD4+CD25? | |||||||||||||||
| |||||||||||||||
|
CD25, i.e. the IL2R, is more easily detected in vitro), and to its kinetics, peaking relatively late (whereas e.g. | |||||||||||||||
| |||||||||||||||
|
In our study, we have demonstrated that repetitive PTx treatment elevated frequency as well as mean FoxP3 expression of CD4+CD25+FoxP3+ T cells. | |||||||||||||||
| |||||||||||||||
|
At four days post-transduction, B cells expressing M2 were CD19+, CD25high, GL7high, B220low, I-Ab low, surface IgD? | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.